SIP 2016 “Time for Action!”
The 6th Societal Impact of Pain (SIP) symposium takes place in Brussels / Belgium on 23-24 May 2016 and brings together international experts in the field of pain care, along with patient representatives, policy makers and other stakeholders in the field of pain policy.
Topics for discussion this year are:
- Pain as a quality indicator for health care
- Chronic Pain: a disease or multi-morbidity?
- The relevance of pain in cancer care and rehabilitation
- Pain, rehabilitation and reintegration of workers in the working force
Taking place under the high patronage of the Italian Ministry of Health, SIP 2016 focuses on areas of EU policy that affect pain care and aims to have a lasting political impact, with conclusions expected to be enshrined in the EU policy-making process through their inclusion in a European Parliament Resolution.
SIP 2016 is co-hosted by the following Members of the European Parliament (MEPs): Clara Eugenia Aguilera García, Heinz K. Becker, Soledad Cabezón Ruiz, Nicola Caputo, Theresa Griffin, José Inácio Faria, Takis Hadjigeorgiou, Marian Harkin, Merja Kyllönen, Giovanni La Via, Jeroen Lenaers, Roberta Metsola, Piernicola Pedicini, Sirpa Pietikainen and Sabine Verheyen. It is also supported by MEPs Francoise Grossetête, Therese Comodini Cachia, Miriam Dalli, Agnes Jongerius and Alfred Sant.
The whole MEP Interest Group on Brain, Mind and Pain is also endorsing the scientific aims of the event, and will be taking stock of the recommendations arising from the SIP working group on ‘Pain, rehabilitation and reintegration of workers in the workforce’ to move things forward within the European Parliament on the topic.
The scientific framework of the SIP symposium and platform is under the responsibility of the European Pain Federation EFIC®. This year’s edition sees for the first time the formal cooperation of the patient community, represented by Pain Alliance Europe (PAE), and the civil society, represented by Active Citizenship Network (ACN), partners for SIP 2016, further providing added value in addressing the topic of the societal impact of pain. The pharmaceutical company Grünenthal GmbH is responsible for funding and non-financial support (e.g. logistical support). The objectives of this years‘ SIP 2016 symposium have been endorsed by 160 pain advocacy and scientific organisations. For more details https://www.sip-platform.eu/
